Aromasin

Utilised to manage hormone responsive tumours to alleviate growth pathways and support endocrine maintenance protocols.

Dosage

Pack size

You will receive a quality generic equivalent of Aromasin, depending on stock.

Prescription and consultation requirements for Aromasin vary by destination and are determined by the fulfilment partner.

Aromasin details

Condition: Breast Cancer
Alternative names: exemestane
Therapeutic class: Steroidal Aromatase Inhibitor
Pharmacological class: Aromatase Inhibitor
Contraindications: pregnancy; premenopausal status; hypersensitivity to exemestane
Minor side effects: hot flashes; fatigue; joint pain
Moderate side effects: increased sweating; insomnia; nausea
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Originator: Pfizer
Onset Time: 2–4 weeks
Duration: 24 hours
Storage instructions: Store below 25°C.
Drug interactions: Rifampin; St. John's Wort; Estrogen-containing medications
Age restrictions: Approved for postmenopausal females.

Serious side effects

anaphylaxis, requires immediate medical attention; severe osteoporosis, requires immediate medical attention

Patient summary

utilised to manage hormone responsive tumours to alleviate growth pathways and support endocrine maintenance protocols.

Mechanism of action

Irreversibly binds to and inactivates the aromatase enzyme, causing sub-detectable estrogen levels in postmenopausal women.

Pregnancy and breastfeeding

TGA Category X: Strictly contraindicated due to fetal toxicity. Breastfeeding: Do not use.

Aromasin is the originator brand name, made by Pfizer. We use it to identify the medicine and are not affiliated with Pfizer.

The fulfilment partner confirms whether the exact brand or an equivalent containing Exemestane is offered.
The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
Check the final product details at checkout before confirming an order.